Minorities are more likely to suffer the ill effects of cancer than their white counterparts and few enter the field of cancer research. In response to these disparities, NCI has initiated a Minority Institution (MI)/Cancer Center (CC) Partnership program. The program is directed at building cancer research capacity at the MI and increasing the number of under- represented minorities involved in cancer research. New Mexico State University (NMSU) is a Carnegie Foundation """"""""Doctoral/Research University-Extensive"""""""" MI with a successful history of training underrepresented and conducting biomedical research. Fred Hutchinson Cancer Research Center (FHCRC) is an internationally recognized NCI designated cancer center. The partnership between NMSU and FHCRC will provide NMSU formal access to resources and expertise in cancer research. The FHCRC will gain a formal linking with an accomplished NI in order to increase minority presence in its training and research programs. The long term objective of this program is to build cancer research capacity at NMSU and increase minority participation in FHCRC cancer research and education programs. The objectives of this partnership are to: 1) Establish a long-lasting infrastructure to conduct cancer research at NMSU. Components of the infrastructure will include a) a plan for recruiting new and existing NMSU faculty into cancer research; 2) the development of an exchange program for faculty and students between the two institutions; and c) the establishment of a research curriculum t NMSU that will increase knowledge of and skills to address cancer disparities among minority populations. 2.) Develop a structure to recruit, train, train, and mentor undergraduate and graduate minority students for careers in cancer research. Building on existing programs at NMSU, formal links will be established to ensure that such avenues are available for minority students. 3) Provide both NMSU and FHCRC with new research experiences that will benefit scientists at both institutions as well as the populations served by each institution. This will be accomplished initially by conducting 5 pilot projects during the first three years of the grant with others to follow in years 4 and 5.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Exploratory Grants--Cooperative Agreements (U56)
Project #
1U56CA096288-01
Application #
6488596
Study Section
Special Emphasis Panel (ZCA1-SRRB-7 (J1))
Program Officer
Aguila, H Nelson
Project Start
2002-06-12
Project End
2007-05-31
Budget Start
2002-06-12
Budget End
2003-05-31
Support Year
1
Fiscal Year
2002
Total Cost
$266,277
Indirect Cost
Name
Fred Hutchinson Cancer Research Center
Department
Type
DUNS #
075524595
City
Seattle
State
WA
Country
United States
Zip Code
98109
Thompson, Beti; O'Connell, Mary; Löest, Helena et al. (2013) Understanding and reducing obstacles in a collaboration between a minority institution and a cancer center. J Health Care Poor Underserved 24:1648-56
Shuster, Michele; Peterson, Karen (2009) Development, implementation, and assessment of a lecture course on cancer for undergraduates. CBE Life Sci Educ 8:193-202
O'Keefe, David D; Gonzalez-Niño, Eduardo; Burnett, Micheal et al. (2009) Rap1 maintains adhesion between cells to affect Egfr signaling and planar cell polarity in Drosophila. Dev Biol 333:143-60
O'Keefe, David D; Prober, David A; Moyle, Patrick S et al. (2007) Egfr/Ras signaling regulates DE-cadherin/Shotgun localization to control vein morphogenesis in the Drosophila wing. Dev Biol 311:25-39
Coronado, Gloria D; Farias, Argelia; Thompson, Beti et al. (2006) Attitudes and beliefs about colorectal cancer among Mexican Americans in communities along the US-Mexico border. Ethn Dis 16:421-7
George, Olivia; Johnston, Mantissa A; Shuster, Charles B (2006) Aurora B kinase maintains chromatin organization during the MI to MII transition in surf clam oocytes. Cell Cycle 5:2648-56
Li, C I; Uribe, D J; Daling, J R (2005) Clinical characteristics of different histologic types of breast cancer. Br J Cancer 93:1046-52